Nkarta
NKTX· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock -25.7% in FY2025
Paul Hastings is the CEO of Nkarta and was paid $3.0M in FY2025 (Dec), down 25%.
Pay$100 in the stock at the end of FY21 → $12
Executives3
See all- 1Paul HastingsChief Executive OfficerFY2025
- 2Nadir Mahmood, Ph.D.PresidentFY2025
- 3Shawn Rose, M.D., Ph.D.Chief Medical Officer and Head of Research and DevelopmentFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allNkarta paid its 3 named executives $5.6M in total in FY2025 (Dec). CEO Paul Hastings was paid $3.0M of that.
| Name | |||
|---|---|---|---|
| Paul HastingsChief Executive Officer | |||
| Nadir Mahmood, Ph.D.President | |||
| Shawn Rose, M.D., Ph.D.Chief Medical Officer and Head of Research and Development | Not disclosed | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Nkarta. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board5
See all- Michael DybbsDirector · 6 yr on the boardIndependentCompensation (Chair), Nominating and Governance, Science and Technology—Paid as an executive
- Leone PattersonDirector · 5 yr on the boardIndependentAudit (Chair)—Paid as an executive
- Simeon GeorgeDirector · 5 yr on the boardIndependentCompensation—Paid as an executive
- Zachary ScheinerDirector · 5 yr on the boardIndependentNominating and Governance, Science and Technology—Paid as an executive
- Angela ThedingaDirector · 3 yr on the boardIndependentAudit, Compensation, Science and Technology (Chair)—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 23, 2026 | FY2025 |
| Annual report | 10-K | Mar 25, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 21, 2025 | FY2024 |
| Annual report | 10-K | Mar 26, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 25, 2024 | FY2023 |
| Annual report | 10-K | Mar 21, 2024 | FY2023 |
